Fresenius Medical Care AG / DE0005785802

Fresenius Medical Care AG: Share buyback Disclosure pursuant to Art. 5 para. 1 lit. b) of Regulation (EU) No. 596/2014 Share buyback – Interim Report In the period from November 3, 2025 to November 7, 2025 (each inclusive), 1,105,000 shares were bought back within the framework of the share buyback of Fresenius Medical Care AG, the start of which was disclosed on August 11, 2025 pursuant to Art. 5 para. 1 lit. a) of Regulation (EU) No. 596/2014, Art. 2 para. 1 of Delegated Regulation (EU) 2016/1052. Shares were bought back as follows:

Date	Acquired shares (number)	Weighted average price (in EUR)	Transaction volume (in EUR)	Trading venue
3 November 2025	135,000	46.1129	6,225,240.36	XETA
4 November 2025	12,000	42.1359	505,630.51	AQEU
4 November 2025	69,000	42.1331	2,907,186.46	CEUX
4 November 2025	9,000	42.1287	379,158.63	TQEX
4 November 2025	130,000	42.6282	5,541,667.42	XETA
5 November 2025	10,000	41.6334	416,334.03	AQEU
5 November 2025	81,000	41.6095	3,370,370.88	CEUX
5 November 2025	10,000	41.6120	416,120.30	TQEX
5 November 2025	149,000	41.5997	6,198,355.03	XETA
6 November 2025	6,000	42.3751	254,250.71	AQEU
6 November 2025	85,000	42.3714	3,601,571.67	CEUX
6 November 2025	5,000	42.3863	211,931.39	TQEX
6 November 2025	154,000	42.3688	6,524,787.76	XETA
7 November 2025	15,000	41.6781	625,171.41	AQEU
7 November 2025	75,000	41.6765	3,125,736.55	CEUX
7 November 2025	10,000	41.6743	416,742.52	TQEX
7 November 2025	150,000	41.6844	6,252,665.74	XETA

A total of 5,457,783 shares have been acquired within the framework of this share buyback. The purchase of the shares is carried out by a credit institution commissioned by Fresenius Medical Care AG. Fresenius Medical Care AG will provide regular information regarding the progress of the share buyback, including by posting its required disclosures at https://freseniusmedicalcare.com/en/investors/shares/share-buyback/.